Cargando…

Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Santos, Marta, Corma-Gómez, Anais, Macías, Juan, Pineda, Juan Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2023
Materias:	Scientific Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890373/ https://www.ncbi.nlm.nih.gov/pubmed/36737365 http://dx.doi.org/10.1016/j.eimce.2022.10.012

Ejemplares similares

Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
por: Santos, Marta, et al.
Publicado: (2023)

Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV
por: Macías, Juan, et al.
Publicado: (2022)

Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV
por: Corma-Gómez, Anaïs, et al.
Publicado: (2022)

Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide
por: Santos, Marta, et al.
Publicado: (2023)

Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection
por: Fernandez-Fuertes, M., et al.
Publicado: (2020)

Incidence of and factors associated with SARS‐CoV‐2 infection among people living with HIV in Southern Spain after one year of pandemic
por: Fernandez‐Fuertes, Marta, et al.
Publicado: (2021)

A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure
por: Corma-Gómez, Anaïs, et al.
Publicado: (2021)

Hospital admissions due to coronary events during SARS-CoV2 pandemic()
por: Carrión-Sánchez, Irene, et al.
Publicado: (2021)

Hepatitis E Virus Infection in HIV-infected Persons
por: Crum-Cianflone, Nancy F., et al.
Publicado: (2012)

The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients
por: Núñez-Torres, Rocío, et al.
Publicado: (2016)

Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study
por: Neukam, Karin, et al.
Publicado: (2016)

Autoimmune hepatitis. Another consequence of COVID-19?
por: Andrés, Laura, et al.
Publicado: (2023)

Comment on: One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus
por: Vermeulen, Marion
Publicado: (2013)

Evidence for Independent Hepatitis E Virus Replication in the Brain
por: den Drijver, Evert P.M., et al.
Publicado: (2021)

Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
por: González-Castro, A., et al.
Publicado: (2022)

Coinfection with Hepatitis C and HIV Is a Risk Factor for Poor Outcomes After Total Knee Arthroplasty
por: Mahure, Siddharth A., et al.
Publicado: (2017)

Severe Cholestatic Hepatitis Secondary to SARS-CoV-2
por: Lindholm, Christopher R., et al.
Publicado: (2022)

Public health risks associated with hepatitis E virus (HEV) as a food‐borne pathogen
por: Ricci, Antonia, et al.
Publicado: (2017)

Usefulness of chest ultrasound in a neonatal infection due to SARS-CoV-2()
por: Pineda Caplliure, Ana, et al.
Publicado: (2021)

Detection of respiratory viruses in patients with suspected SARS-CoV-2 infection()
por: Reina, Jordi, et al.
Publicado: (2021)

When success means focusing on the oxygen delivery. A case of conventional management of severe hypoxemia in SARS-CoV-2
por: Franqueza, J.L., et al.
Publicado: (2021)

When success means focusing on the oxygen delivery. A case of conventional management of severe hypoxemia in SARS-CoV-2
por: Franqueza, J.L., et al.
Publicado: (2021)

Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
por: Galvis, Virgilio, et al.
Publicado: (2020)

SARS-CoV-2 and Legionella pneumophila coinfection
por: Argemí, Gemma, et al.
Publicado: (2022)

SARS-CoV-2 and Legionella pneumophila coinfection
por: Argemí, Gemma, et al.
Publicado: (2022)

COVID and CARE®. Mobile application for monitoring SARS-CoV-2 positive patients after hospitalization
por: Gómez Rebollo, Cristina, et al.
Publicado: (2021)

COVID and CARE®. Mobile application for monitoring SARS-CoV-2 positive patients after hospitalization
por: Gómez Rebollo, Cristina, et al.
Publicado: (2021)

Molecular Characteristics of Hepatitis B Virus among Children Vaccinated with HBsAg Positive in Huzhou, China
por: Jin, Fang, et al.
Publicado: (2022)

Laparoscopic Management of Hepatic Hydatid Disease
por: Palanivelu, C, et al.
Publicado: (2006)

Evaluating an Ultraviolet C System for Use During SARS-CoV2 Pandemic and Personal Protective Equipment Shortage
por: Dunn, Emily F., et al.
Publicado: (2020)

Development of a test system for simultaneous detection of HIV RNA and Hepatitis C virus (HCV) and DNA of Hepatitis B virus (HBV) in blood samples
por: Shahrokhi, Nader, et al.
Publicado: (2010)

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain
por: Rivero-Juarez, Antonio, et al.
Publicado: (2020)

Su322 SEVERE CHOLESTATIC HEPATITIS SECONDARY TO SARS-COV-2
por: Lindholm, Christopher R., et al.
Publicado: (2021)

SARS-CoV-2 infection in patients with sickle cell disease()
por: Argüello-Marina, María, et al.
Publicado: (2021)

The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2021)

Myocardial injury as a prognostic factor in critically ill patients with severe SARS-Cov-2 pneumonia
por: Villavicencio, C., et al.
Publicado: (2023)

Myocardial injury as a prognostic factor in critically ill patients with severe SARS-Cov-2 pneumonia
por: Villavicencio, C., et al.
Publicado: (2023)

Pneumocystis jirovecii and SARS-CoV-2 Coinfection as Presentation of X-linked Severe Combined Immunodeficiency
por: Toledano-Revenga, Javier, et al.
Publicado: (2023)

Evidence of Hepatitis A Virus Person-to-Person Transmission in Household Outbreaks
por: Lima, Lyana Rodrigues, et al.
Publicado: (2014)

High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
por: Macías, Juan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2lkc6vr1dv0t30k04co0g9avd8